EU edges toward agreed policy on hormone disrupting chemicals
The EU edged closer Tuesday toward a common stand on chemicals which can potentially disrupt the body's hormones and cause a range of serious health problems.
Jul 4, 2017
0
46
The EU edged closer Tuesday toward a common stand on chemicals which can potentially disrupt the body's hormones and cause a range of serious health problems.
Jul 4, 2017
0
46
(HealthDay)—For patients with breast cancer receiving endocrine therapy, daily bidirectional text messaging can monitor adherence and adverse events (AEs), according to a study published online May 23 in JCO: Clinical Cancer ...
May 30, 2017
0
0
All vertebrates – from frogs and birds to human beings – require the same thyroid hormone to thrive. Every stage of brain development is modulated by thyroid hormone and, over millions of years, the structure of this ...
May 11, 2017
0
154
Researchers at the University of Helsinki, Finland, have uncovered a mechanism through which a mutation in the STAT3 gene leads to a disorder in the development of the pancreas and to infant diabetes.
Apr 11, 2017
0
16
A new Scientific Statement issued by the Endocrine Society advises healthcare providers on ways to spot hormonal causes of high blood pressure that can be cured with surgery or treated effectively with medication.
Apr 6, 2017
0
0
Exposure during infancy to the common plasticizer bisphenol A (BPA) "hijacks" and reprograms genes in the liver of newborn rats, leading to nonalcoholic fatty liver disease (NAFLD) in adulthood. A new study has found how ...
Apr 2, 2017
0
4
(HealthDay)—For women with early-stage, hormone receptor-positive invasive breast cancer, initiation of cholesterol-lowering medication (CLM) during endocrine therapy is associated with improved survival and distant recurrence-free ...
Feb 15, 2017
0
10
A nationwide cancer registry of almost one million patients treated for hormone-sensitive breast cancer shows that one out of six women who should have received post-surgical treatment known as adjuvant endocrine therapy ...
Feb 2, 2017
0
0
Ribociclib significantly improves progression-free survival in Asian women with advanced breast cancer, according to a sub-analysis of the MONALEESA-2 trial presented at the ESMO Asia 2016 Congress in Singapore.
Dec 17, 2016
0
2
Around 20% of breast cancer patients do not complete prescribed endocrine therapy, researchers report at the ESMO Asia 2016 Congress in Singapore. The study in over 5,500 women found that younger patients and those who had ...
Dec 14, 2016
0
0